Suboxone is British drugmaker Indivior's best-selling opioid addiction treatment drug in the US. Shares of Indivior tanked about 47 percent on Tuesday, in a record single-day fall. Jefferies analysts said they consider the ruling to be near-term positive, and one that allows the company to immediately re-launch the product, but still at-risk.

Both benchmark indices - Sensex and Nifty - recorded their third straight weekly gains by rising 298.61 points and 97 points, respectively.

Ruchit Jain, Technical Analyst at Angel Broking, takes viewers through all the market action today. The equity benchmark Sensex Tuesday recouped nearly 332 points following robust buying in energy, infra and banking stocks amid easing crude oil prices and strong recovery in the rupee. Similarly, the broader NSE Nifty jumped over 100 points to cross the key 10,500 level.

However, most Asian markets ended lower after a rout in tech stocks, tracking a hefty sell-off on Wall Street, while the dollar hit a 16-month peak on safe haven bets amid China-US trade war worries.

Tata Motors (4.84%), Hero MotoCorp (3.82%) and PowerGrid 2.87% were the top Sensex losers. Of 30 Sensex stocks, 25 closed lower.